Roundup of Retina Subspecialty Day

Dr. Barbara Blodi, co-chair of Retina Subspecialty Day 2023, spoke with Dr. Ajay Kuriyan about highlights of this year's program. Key topics included the debate over surgery vs medical management for proliferative diabetic retinopathy and updates on geographic atrophy, including discussions on both treatment and prevention. She also discussed her presentation on the use of Optos and Clarus ultrawide-field imaging systems vs standard imaging for assessing the severity of diabetic retinopathy.

Financial Disclosures: Dr. Ajay Kuriyan discloses financial relationships with 4DMT, Adverum, Annexon, National Eye Institute, Novartis, Alcon Pharmaceuticals (Grant Support); Alimera Sciences, Allergan, Bausch + Lomb, EyePoint Pharmaceuticals (Consultant/Advisor); Iveric Bio, Optos (Lecture Fees/Speakers Bureau); Lumata Health, Recens Medical (Consultant/Advisor, Private Equity/Stock Holder); Spark Therapeutics (Consultant/Advisor, Lecture Fees/Speakers Bureau); Genentech (Consultant/Advisor, Lecture Fees/Speakers Bureau, Grant Support). Dr. Barbara Blodi discloses no financial relationships.